HI
LKFT

Harbour Investments’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Harbour Investments’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-408
Closed -$21K – 3050
2021
Q3 		$21K Buy
408
+69
+20% +$4.1K ﹤0.01% 2268
2021
Q2 		$23K Sell
339
-57
-14% -$4.35K ﹤0.01% 2266
2021
Q1 		$31K Buy
+396
New +$36.5K ﹤0.01% 1948

Other funds holding LKFT

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Harbour Investments's LKFT Position: Q4 2021 in Review

Harbour Investments sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2021, closing a stake of 408 shares — an estimated $21K sold.

Harbour Investments first reported a position in LKFT in Q1 2021 and held it in 3 quarters. The position peaked at $31K in Q1 2021. 83 funds tracked by Wall St. Rank hold LKFT as of Q4 2021.

  • Harbour Investments reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2021 after selling out during the quarter.
  • Harbour Investments sold 408 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2021, an estimated $21K.
  • Harbour Investments first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2021 and held it in 3 quarters.
  • Harbour Investments's Lakefront Biotherapeutics American Depositary Shares position peaked at $31K in Q1 2021.
  • 83 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2021.

Based on Harbour Investments's 13F filing for Q4 2021, filed 16 Feb 2022.